|
|
||||||||
Review Article |
Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (S.J.P., A.K., Y.W., P.E., O.K., J.-H.L., S.C., C.C., M.L.), Maryland
Division of Gastroenterology, Sinai Hospital of Baltimore, University of Maryland School of Medicine, Baltimore (A.D., S.K.D.), Maryland
Address correspondence to: Mark Levine MD, Molecular and Clinical Nutrition Section, Digestive Diseases Branch, Building 10, Room 4D52, MSC 1372, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1372. E-mail: MarkL{at}intra.niddk.nih.gov
Vitamin C in humans must be ingested for survival. Vitamin C is an electron donor, and this property accounts for all its known functions. As an electron donor, vitamin C is a potent water-soluble antioxidant in humans. Antioxidant effects of vitamin C have been demonstrated in many experiments in vitro. Human diseases such as atherosclerosis and cancer might occur in part from oxidant damage to tissues. Oxidation of lipids, proteins and DNA results in specific oxidation products that can be measured in the laboratory. While these biomarkers of oxidation have been measured in humans, such assays have not yet been validated or standardized, and the relationship of oxidant markers to human disease conditions is not clear. Epidemiological studies show that diets high in fruits and vegetables are associated with lower risk of cardiovascular disease, stroke and cancer, and with increased longevity. Whether these protective effects are directly attributable to vitamin C is not known. Intervention studies with vitamin C have shown no change in markers of oxidation or clinical benefit. Dose concentration studies of vitamin C in healthy people showed a sigmoidal relationship between oral dose and plasma and tissue vitamin C concentrations. Hence, optimal dosing is critical to intervention studies using vitamin C. Ideally, future studies of antioxidant actions of vitamin C should target selected patient groups. These groups should be known to have increased oxidative damage as assessed by a reliable biomarker or should have high morbidity and mortality due to diseases thought to be caused or exacerbated by oxidant damage.
Abbreviations: LDL = low density lipoprotein 8OHdG = 8-hydroxy-2'-deoxyguanosine SVCT = sodium dependent vitamin C transporter NO = nitric oxide
Key words: ascorbic acid, oxidation, diet, low-density lipoproteins
This article has been cited by other articles:
![]() |
Q. Chen, M. G. Espey, A. Y. Sun, C. Pooput, K. L. Kirk, M. C. Krishna, D. B. Khosh, J. Drisko, and M. Levine From the Cover: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice PNAS, August 12, 2008; 105(32): 11105 - 11109. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans J. Physiol., July 15, 2008; 586(14): 3525 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Franky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, H. R. H. Patel, and Prabhudas Shankerbhai Patel Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer Integr Cancer Ther, March 1, 2008; 7(1): 33 - 41. [Abstract] [PDF] |
||||
![]() |
L. Robert, A. Narcy, Y. Rayssiguier, A. Mazur, and C. Remesy Lipid Metabolism and Antioxidant Status in Sucrose vs. Potato-Fed Rats J. Am. Coll. Nutr., February 1, 2008; 27(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K Myint, R. N Luben, A. A Welch, S. A Bingham, N. J Wareham, and K.-T. Khaw Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study Am. J. Clinical Nutrition, January 1, 2008; 87(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Padayatty and M. Levine Reply to V Bahr et al Am. J. Clinical Nutrition, January 1, 2008; 87(1): 191 - 192. [Full Text] [PDF] |
||||
![]() |
C. L. Linster, T. A. Gomez, K. C. Christensen, L. N. Adler, B. D. Young, C. Brenner, and S. G. Clarke Arabidopsis VTC2 Encodes a GDP-L-Galactose Phosphorylase, the Last Unknown Enzyme in the Smirnoff-Wheeler Pathway to Ascorbic Acid in Plants J. Biol. Chem., June 29, 2007; 282(26): 18879 - 18885. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agudo, L. Cabrera, P. Amiano, E. Ardanaz, A. Barricarte, T. Berenguer, M. D Chirlaque, M. Dorronsoro, P. Jakszyn, N. Larranaga, et al. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain) Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1634 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Montecinos, P. Guzman, V. Barra, M. Villagran, C. Munoz-Montesino, K. Sotomayor, E. Escobar, A. Godoy, L. Mardones, P. Sotomayor, et al. Vitamin C Is an Essential Antioxidant That Enhances Survival of Oxidatively Stressed Human Vascular Endothelial Cells in the Presence of a Vast Molar Excess of Glutathione J. Biol. Chem., May 25, 2007; 282(21): 15506 - 15515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. M. Vissers and R. P. Wilkie Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1{alpha} J. Leukoc. Biol., May 1, 2007; 81(5): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. SHAMSI, A. AMIN, and E. ADEGHATE Effect of Vitamin C on Liver and Kidney Functions in Normal and Diabetic Rats Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 371 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Nantz, C. A. Rowe, C. Nieves Jr., and S. S. Percival Immunity and Antioxidant Capacity in Humans Is Enhanced by Consumption of a Dried, Encapsulated Fruit and Vegetable Juice Concentrate J. Nutr., October 1, 2006; 136(10): 2606 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Catley and K. C. Anderson Velcade and Vitamin C: Too Much of a Good Thing? Clin. Cancer Res., January 1, 2006; 12(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
H. Chen, R. J. Karne, G. Hall, U. Campia, J. A. Panza, R. O. Cannon III, Y. Wang, A. Katz, M. Levine, and M. J. Quon High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H137 - H145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jenab, S. Bingham, P. Ferrari, M. D. Friesen, W. K. Al-Delaimy, R. Luben, N. Wareham, K.-T. Khaw, and E. Riboli Long-term Cryoconservation and Stability of Vitamin C in Serum Samples of the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1837 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gonzalez, J. R. Miranda-Massari, E. M. Mora, A. Guzman, N. H. Riordan, H. D. Riordan, J. J. Casciari, J. A. Jackson, and A. Roman-Franco Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later Integr Cancer Ther, March 1, 2005; 4(1): 32 - 44. [Abstract] [PDF] |
||||
![]() |
M. L. Kwan, G. Block, S. Selvin, S. Month, and P. A. Buffler Food Consumption by Children and the Risk of Childhood Acute Leukemia Am. J. Epidemiol., December 1, 2004; 160(11): 1098 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Salnikow, S. P. Donald, R. K. Bruick, A. Zhitkovich, J. M. Phang, and K. S. Kasprzak Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress J. Biol. Chem., September 24, 2004; 279(39): 40337 - 40344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Padayatty, H. Sun, Y. Wang, H. D. Riordan, S. M. Hewitt, A. Katz, R. A. Wesley, and M. Levine Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use Ann Intern Med, April 6, 2004; 140(7): 533 - 537. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |